MYC can enforce cell cycle transit from G1 to S and G 2 to S, but not mitotic cellular division, independent of p27-mediated inihibition of cyclin E/CDK2

Cell Cycle

Volumn 5, Issue 12, 2006, Pages 1348-1355

  Deb Basu, Debabrita ^a   Karlsson, Åsa ^a   Li, Qing ^b   Dang, Chi V ^b,c   Felsher, Dean W ^a  

^a STANFORD UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

CDK2; CyclinE; Endo reduplication; MYC; p27

Indexed keywords

CYCLIN DEPENDENT KINASE 2; CYCLIN E; MYC PROTEIN; PROTEIN P27; TRANSCRIPTION FACTOR;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BREAST EPITHELIUM; CARCINOGENESIS; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL DIVISION; CONTROLLED STUDY; DNA REPLICATION; ENDOREDUPLICATION; ENZYME INHIBITION; EXPERIMENTAL MODEL; FIBROBLAST; GENE OVEREXPRESSION; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; KARYOTYPING; MITOSIS; NONHUMAN; ONCOGENE MYC; PROTEIN EXPRESSION; PROTO ONCOGENE; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

PROTEA;

EID: 33745179524     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.5.12.2860     Document Type: Article

References (56)

1. Dang CV. c-MYC target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol 1999; 19:1-11.
2. Oster SK, Ho CS, Soucie EL, Penn LZ. The myc oncogene: MarvelouslY Complex. Adv Cancer Res 2002; 84:81-154.
3. Eisenman RN. Deconstructing myc. Genes Dev 2001; 15:2023-30.
4. Pelengaris S, Khan M, Evan G. c-MYC: More than just a matter of life and death. Nat Rev Cancer 2002; 10:764-66.
5. Zindy F, Eischen CM, Randle DH, Kamijo T, Cleveland JL, Sherr CJ. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev 1998; 12:2424-33.
6. Simm A, Halle JP, Adam G. Proliferative and metabolic capacity of rat embryo fibroblasts immortalized by c-myc depends on cellular age at oncogenic transfection. Eur J Cell Biol 1994; 65:121-31.
7. Vafa O, Wade M, Kern S, Beeche M, Pandita TK, Hampton GM, Wahl GM. c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: A mechanism for oncogene-induced genetic instability. Mol Cell 2002; 9:1031-44.
8. Pelengaris S, Littlewood T, Khan M, Elia G, Evan G. Reversible activation of c-Myc in skin: Induction of a complex neoplastic phenotype by a single oncogenic lesion. Mol Cell 1999; 3:565-77.
9. Li Q, Dang CV. c-Myc overexpression uncouples DNA replication from mitosis. Mol Cell Biol 1999; 19:5339-51.
10. Mai S, JH-H, Fluri M. c-MYC overexpression associated DHFR gene amplification in hamster, rat, mouse and human cell lines. Oncogene 1996; 12:277-88.
11. Marcu KB, Bossone SA, Patel AJ. myc function and regulation. Annu Rev Biochem 1992:809-60.
12. Inghirami G, Grignani F, Sternas L, Lombardi L, Knowles DM, Dalla-Favera R. Downregulation of LFA-1 adhesion receptors by C-myc oncogene in human B lymphoblastoid cells. Science 1990; 250:682-6.
13. Harrington EA, Bennett MR, Fanidi A, Evan GI. c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. Embo J 1994; 13:3286-95.
14. Felsher DW, Bishop JM. Transient excess of MYC activity can elicit genomic instability and tumorigenesis. Proc Natl Acad Sci USA 1999; 96:3940-4.
15. Cerni C, Mougneau E, Cuzin F. Transfer of 'immortalizing' oncogenes into rat fibroblasts induces both high rates of sister chromatid exchange and appearance of abnormal karyotypes. Exp Cell Res 1987; 168:439-46.
16. Coller HA, Grandori C, Tamayo P, Colbert T, Lander ES, Eisenman RN, Golub TR. Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion. Proc Natl Acad Sci USA 2000; 97:3260-5.
17. Barr LF, Campbell SE, Bochner BS, Dang CV. Association of the decreased expression of alpha3beta1 integrin with the altered cell: Environmental interactions and enhanced soft agar cloning ability of c-myc-overexpressing small cell lung cancer cells. Cancer Res 1998; 58:5537-45.
18. Chernova OB, Chernov MV, Ishizaka Y, Agarwal ML, Stark GR. MYC abrogates p53-mediated cell cycle arrest in N-phpsphonacetyl-L-aspartate-treated cells, permitting CAD gene amplification. Mol Cell Biol 1998; 18:536-45.
19. Baudino TA, McKay C, Pendeville-Samain H, Nilsson JA, Maclean KH, White EL, Davis AC, Ihle JN, Cleveland JL. c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression. Genes Dev 2002; 16:2530-43.
20. Ngo CV, Gee M, Akhtar N, Yu D, Volpert O, Auerbach R, Thomas-Tikhonenko A. An in vivo function for the transforming Myc protein: Elicitation of the angiogenic phenotype. Cell Growth Differ 2000; 11:201-10.
21. Janz A, Sevignani C, Kenyon K, Ngo CV, Thomas-Tikhonenko A. Activation of the myc oncoprotein leads to increased turnover of thrombospondin-1 mRNA. Nucleic Acids Res 2000; 28:2268-75.
22. Yin X, Grove Y, Datta L, NS, Katula K, Long MW, Prochownik EV. Inverse regulation of cyclin B1 by c-Myc and p53 and induction of tetraploidy by cyclin B1 overexpression. Cancer Res 2001; 61:6487-93.
23. 2 arrest of normal fibroblasts. Proc Natl Academy Sci USA 2000; 97:10544-48.
24. Karlsson A, Deb-Basu D, Cherry A, Turner S, Ford J, Felsher DW. Defective double-strand DNA break repair and chromosomal translocations by MYC overexpression. Proc Natl Acad Sci USA 2003; 100:9974-9.
25. Mumberg D, Haas K, Moroy T, Niedenthal R, Hegemann JH, Funk M, Muller R. Uncoupling of DNA replication and cell cycle progression by human cyclin E. Oncogene 1996; 13:2493-7.
26. Jansen-Durr P, Meichle A, Steiner P, Pagano M, Finke K, Botz J, Wessbecher J, Draetta G, Eilers M. Differential modulation of cyclin gene expression by MYC. Proc Natl Acad Sci USA 1993; 90:3685-9.
27. Perez-Roger IS, DL, Sewing A, Land H. Myc activation of cyclin E/Cdk2 kinase involves induction of cyclin E gene transcription and inhibition of p27(Kip1) binding to newly formed complexes. Oncogene 1997; 14:2373-81.
28. 1 cyclin that binds Cdk2 and is aberrantly expressed in human cancers. Mol Cell Biol 1999; 19:612-22.
29. 1 cyclin and activating partner of CDK2 and CDK3, is induced by viral oncoproteins. Oncogene 1998; 17:2787-98.
30. 1 and S phases of the mammalian cell cycle. Oncogene 1998; 17:2637-43.
31. Karn J, Watson JV, Lowe AD, Green SM, Vedeckis W. Regulation of cell cycle duration by c-myc levels. Oncogene 1989; 4:773-87.
32. Alevizopoulos K, Vlach J, Hennecke S, Amati B. Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins. EMBO J 1997; 16:5322-33.
33. Hermeking H, Funk JO, Reichert M, Ellwart JW, Eick D. Abrogation of p53-induced cell cycle arrest by c-Myc: Evidence for an inhibitor of p21WAF1/CIP1/SDI1. Oncogene 1995; 11:1409-15.
34. Vlach J, Hennecke S, Alevizopoulos K, Conti D, Amati B. Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-MYC. EMBO J 1996; 15:6595-604.
35. Hoang AT, Lutterbach B, Lewis BC, Yano T, Chou TY, Barrett JF, Raffeld M, Hann SR, Dang CV. A link between increased transforming activity of lymphoma-derived MYC mutant alleles, their defective regulation by p107, and altered phosphorylation of the c-Myc transactivation domain. Mol Cell Biol 1995; 15:4031-42.
36. Hermeking H, Rago C, Schuhmacher M, Li Q, Barrett JF, Obaya AJ, O'Connell BC, Mateyak MK, Tam W, Kohlhuber F, Dang CV, Sedivy JM, Eick D, Vogelstein B, Kinzler KW. Identification of CDK4 as a target of c-MYC. Proc Natl Acad Sci USA 2000; 97:2229-34.
37. Daksis JI, Lu RY, Facchini LM, Marhin WW, Penn LJ. MYC induces cyclin D1 expression in the absence of de novo protein synthesis and links mitogen-stimulated signal transduction to the cell cycle. Oncogene 1994; 9:3635-45.
38. Yang W, Shen J, Wu M, Arsura M, FitzGerald M, Suldan Z, Kim DW, Hofmann CS, Pianetti S, Romieu-Mourez R, Freedman LP, Sonenshein GE. Repression of transcription of the p27(Kip1) cyclin-dependent kinase inhibitor gene by c-MYC Oncogene. Oncogene 2001; 20:1688-702.
39. O'Hagan RC, Ohh M, David G, de Alboran IM, Alt FW, Kaelin Jr WG, DePinho RA. MYC-enhanced expression of Cul1 promotes ubiquitin-dependent proteolysis and cell cycle progression. Genes Dev 2000; 14:2185-91.
40. 1 cyclin-cdk complexes. EMBO Journal 1995; 14:4814-26.
41. Berthet C, Aleem E, Coppola V, Tessarollo L, Kaldis P. Cdk2 knockout mice are viable. Curr Biol 2003; 13:1775-85.
42. Geng Y, Yu Q, Sicinska E, Das M, Schneider JE, Bhattacharya S, Rideout WM, Bronson RT, Gardner H, Sicinski P. Cyclin E ablation in the mouse. Cell 2003; 114:431-43.
43. Parisi T, Beck AR, Rougier N, McNeil T, Lucian L, Werb Z, Amati B. Cyclins E1 and E2 are required for endoreplication in placental trophoblast giant cells. EMBO J 2003; 22:4794-803.
44. Ortega S, Prieto I, Odajima J, Martin A, Dubus P, Sotillo R, Barbero JL, Malumbres M, Barbacid M. Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice. Nat Genet 2003; 35:25-31.
45. Tetsu O, McCormick F. Proliferation of cancer cells despite CDK2 inhibition. Cancer Cell 2003; 3:233-45.
46. Thompson EW, Torri J, Sabol M, Sommers CL, Byers S, Valverius EM, Martin GR, Lippman ME, Stampfer MR, Dickson RB. Oncogene-induced basement membrane invasiveness in human mammary epithelial cells. Clin Exp Metastasis 1994; 12:181-94.
47. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 1998; 95:2509-14.
48. Bouchard C, Dittrich O, Kiermaier A, Dohmann K, Menkel A, Eilers M, Luscher B. Regulation of cyclin D2 gene expression by the Myc/Max/Mad network: Myc-dependent TRRAP recruitment and histone acetylation at the cyclin D2 promoter. Genes Dev 2001; 15:2042-7.
49. 1/S arrest following ionizing radiation. Mol Cell Biol 2002; 22:1819-33.
50. Kuschak TI, Kuschak BC, Taylor CL, Wright JA, Wiener F, Mai S. c-Myc initiates illegitimate replication of the ribonucleotide reductase R2 gene. Oncogene 2002; 21:909-20.
51. Classon M, Henriksson M, Sumegi J, Klein G, Hammarskjold ML. Elevated c-myc expression facilitates the replication of SV40 DNA in human lymphoma cells. Nature 1987; 330:272-4.
52. Louis SF, Vermolen BJ, Garini Y, Young IT, Guffei A, Lichtensztejn Z, Kuttler F, Chuang TC, Moshir S, Mougey V, Chuang AY, Kerr PD, Fest T, Boukamp P, Mai S. c-Myc induces chromosomal rearrangements through telomere and chromosome remodeling in the interphase nucleus. Proc Natl Acad Sci USA 2005; 102:9613-8.
53. Olashaw N, Pledger WJ. Paradigms of growth control: Relation to Cdk activation. Sci STKE 2002; 2002:RE7.
54. Tanaka H, Matsumura I, Ezoe S, Satoh Y, Sakamaki T, Albanese C, Machii T, Pestell RG, Kanakura Y. E2F1 and c-Myc potentiate apoptosis through inhibition of NF-kappaB activity that facilitates MnSOD-mediated ROS elimination. Mol Cell 2002; 9:1017-29.
55. Leone G, DeGregori J, Sears R, Jakoi L, Nevins JR. MYC and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F. Nature 1997; 387:422-6.
56. Beer S, Zetterberg A, Ihrie RA, McTaggart RA, Yang Q, Bradon N, Arvanitis C, Attardi LD, Feng S, Ruebner B, Cardiff RD, Felsher DW. Developmental context determines latency of MYC-induced tumorigenesis. PLoS Biol 2004; 2:e332.